Cost Is the Silent Barrier to Agrylin Adherence

You've established the right treatment plan. Your patient's platelet counts are responding to Anagrelide. Then they stop filling their prescription — not because of side effects, but because of cost.

This scenario is more common than it should be. Brand-name Agrylin costs $600–$650 for a 60-capsule supply. Even generic Anagrelide, at $40–$80 with discount pricing, can strain patients on fixed incomes or high-deductible plans. And with Agrylin's boxed warning about abrupt discontinuation — which can trigger potentially fatal thrombotic events — cost-related non-adherence carries real clinical consequences.

This guide is designed for hematologists, oncologists, and their care teams. It covers the savings programs available for Agrylin, how to connect patients with them, and how to build cost conversations into your workflow so patients stay on therapy.

What Patients Are Actually Paying

Understanding the cost landscape helps you anticipate which patients may struggle:

• Brand Agrylin: $600–$650 for 60 capsules (0.5 mg) — typically a one-month supply at the starting dose
• Generic Anagrelide (retail): Approximately $80 without any discount
• Generic Anagrelide (with discount card): $40–$80 through GoodRx, SingleCare, or similar programs
• Insurance copay (generic): Typically $10–$50 depending on formulary tier and plan design
• Insurance copay (brand): May be significantly higher if placed on a specialty tier; some plans require prior authorization or step therapy through the generic

Patients who fall into the coverage gap — those with high-deductible plans, Medicare Part D donut hole, or no insurance — are at highest risk for non-adherence.

Manufacturer Savings Programs

Takeda Patient Assistance Program

Takeda Pharmaceuticals (formerly Shire) operates a patient assistance program for qualifying patients:

• Program: Shire Cares / Takeda Patient Assistance Program
• Contact: 1-888-CARES-55 (1-888-227-3755)
• Eligibility: Typically for patients who are uninsured or underinsured and meet income requirements
• What it provides: Free or reduced-cost medication for eligible patients

Your office staff can initiate the application process on behalf of the patient. Having the patient's income documentation and insurance status ready speeds up approval.

When to Refer to the Manufacturer Program

• Patient is uninsured and cannot afford the medication
• Patient's insurance doesn't cover Agrylin (brand or generic)
• Patient is in the Medicare Part D coverage gap
• Patient has expressed cost concerns that may affect adherence

Coupon and Discount Card Programs

For patients with commercial insurance or those paying cash, discount cards can significantly reduce out-of-pocket costs for generic Anagrelide:

Top Discount Card Options

• GoodRx: Often brings generic Anagrelide to the $40–$60 range. Patients can download the app or print a coupon at goodrx.com
• SingleCare: Competitive pricing, available at most major pharmacy chains
• RxSaver: Price comparison across nearby pharmacies
• Optum Perks: Another discount option with wide pharmacy acceptance
• BuzzRx: Free discount card accepted at most pharmacies

These programs work at the pharmacy counter — no enrollment or income verification required. They're especially valuable for patients between insurance plans, on high-deductible plans, or paying cash.

Important note: Discount cards cannot be combined with insurance or used by patients on government-funded programs (Medicare, Medicaid, Tricare). Patients should use whichever option — insurance or discount card — gives them the lower price.

Generic Alternatives and Therapeutic Substitution

Generic Anagrelide

The most impactful cost intervention for most patients is simply prescribing generic Anagrelide rather than brand-name Agrylin. The savings are substantial:

• Brand Agrylin: $600–$650/month
• Generic Anagrelide: $40–$80/month with discount card

Generic Anagrelide is therapeutically equivalent and is manufactured by multiple companies. Unless there is a specific clinical reason for the brand (rare), all patients should be on the generic.

If a patient's pharmacy is automatically dispensing the brand due to prescribing conventions, ensure the prescription is written to allow generic substitution.

Therapeutic Alternatives

If cost remains prohibitive even for generic Anagrelide, consider whether a therapeutic alternative might be appropriate:

• Hydroxyurea (Hydrea/Droxia): First-line therapy for essential thrombocythemia and typically less expensive. Generic Hydroxyurea is widely available at low cost. If the patient hasn't tried Hydroxyurea, or if their initial intolerance was dose-related, a rechallenge at a lower dose may be feasible.
• Pegylated Interferon Alfa-2a (Pegasys): Alternative with potential disease-modifying effects. Cost is higher, but some manufacturer assistance programs exist.
• Ropeginterferon Alfa-2b (Besremi): Newer option with promising data from the SURPASS-ET trial showing superior efficacy vs. Anagrelide as second-line therapy. Specialty pricing applies, but manufacturer programs are available.

Therapeutic substitution decisions should be based on clinical factors first, but when two options are clinically appropriate, the more affordable one supports adherence.

Patient Assistance Programs (Non-Manufacturer)

Several independent organizations help patients access medications they can't afford:

• NeedyMeds (needymeds.org) — comprehensive database of assistance programs; searchable by drug name
• RxAssist (rxassist.org) — patient assistance program directory maintained by a non-profit
• RxHope (rxhope.com) — connects patients with manufacturer and foundation programs
• Patient Advocate Foundation — helps patients navigate insurance denials and financial barriers

Consider keeping a printed handout with these resources in your clinic. Patients facing cost barriers often don't know where to start — a simple list can make the difference between adherence and abandonment.

Building Cost Conversations Into Your Workflow

The most effective time to address cost is before it becomes a reason for non-adherence. Here's how to integrate cost awareness into your clinical workflow:

At the Initial Prescription

• Prescribe generic by default: Write for "Anagrelide" rather than "Agrylin" to ensure generic substitution
• Ask about insurance: A quick "Do you have prescription drug coverage?" identifies at-risk patients early
• Mention discount options proactively: "If the cost is more than expected, websites like GoodRx can help bring it down"
• Provide savings resources: Have your staff hand out a printed or digital list of discount card options and patient assistance programs

At Follow-Up Visits

• Ask about adherence directly: "Have you been able to fill your prescription every month?" is more effective than "Are you taking your medication?"
• Screen for cost barriers: "Has the cost of your medication been manageable?" — normalizing the question reduces stigma
• Check refill history: Gaps in refill patterns often signal cost issues before the patient mentions them

Empower Your Staff

• Train medical assistants and nurses to ask about medication costs during intake
• Designate a staff member (or use a social worker) as the point person for assistance program applications
• Keep a quick-reference guide with program phone numbers and websites at the front desk

Use Technology

Tools like Medfinder for Providers can help your practice identify pharmacies with Anagrelide in stock and at competitive prices, reducing the burden on your staff and patients alike.

The Adherence Equation

A medication only works if patients take it. And with Agrylin specifically, the stakes of non-adherence are unusually high — abrupt discontinuation can cause platelet counts to spike, leading to potentially fatal thrombotic events.

Every dollar you help a patient save on Anagrelide is an investment in adherence, outcomes, and trust. Most of these programs take minutes to set up and can save patients hundreds of dollars per month.

Final Thoughts

Cost-related non-adherence is a solvable problem for most Agrylin patients. Generic Anagrelide is affordable with discount cards. Manufacturer and independent assistance programs exist for those who need more help. And the simple act of asking about cost barriers — proactively, without judgment — can prevent treatment interruptions before they happen.

For patient-facing resources on savings, direct them to our guide on how to save money on Agrylin. And for help finding pharmacies with Anagrelide in stock, visit Medfinder for Providers.